K 01-162 (K162) binds and destabilizes AβO (β-amyloid), with an EC50 of 80 nM. References: Li J, et al. Alzheimer's disease drug candidates stabilize A-β protein native structure by interacting with the hydrophobic core. Biophys J. 2011 Feb 16;100(4):1076-82. [2]. Hong HS, et al. Candidate anti-A beta fluorene compounds selected from analogs of amyloid imaging agents. Neurobiol Aging. 2010 Oct;31(10):1690-9.

纯度：≥98%

CAS：677746-25-7